Navigation Links
Top Pharma and Biotech Researchers meet with local Academics for QSP-SB Industry & Academia Symposium

CAMBRIDGE, Mass., Nov. 2, 2015 /PRNewswire/ -- Applied BioMath ( announces the kick-off of the 2015-2016 QSP-SB Industry & Academia Symposium series.    This week, top pharma and biotech representatives will meet along with local faculty, students, and post docs, for the Fall QSP-SB Industry & Academia Symposium.   This Symposium:

  • Is an opportunity for presenting, learning, and discussing quantitative systems pharmacology (QSP) and systems biology (SB) topics.  
  • Aims to foster an active community of industry and academic participants interested in these topics, and create a forum for sharing our successes and challenges. 
  • Is one of three that will be held during the 2015-2016 academic year, alternating between local campuses. 

Dr. John Burke, Co-Founder, President, and CEO of Applied BioMath, realized that such an industry-academic collaboration and networking opportunity was lacking in the QSP and SB community.  He had benefited from and enjoyed a similar type of event hosted by the Cell Decision Process (CDP) Center ( during his post-doc work at MIT and HMS. With strong academic enthusiasm from thought leaders such as Douglas Lauffenburger and Peter Sorger, Dr. Burke and Applied BioMath initiated the QSP-SB Industry & Academia symposium series, modeled closely after the CDP meetings, and held the inaugural symposium last spring.  Overwhelming industry response is more than doubling this year's attendees.  

"As a company with both CEO and CSO having done their post-doc and PhD at MIT respectively, and seeing how the CDP strengthened science and community, I am very excited by the potential of growing this community, to support each other, meet the future modelers, and hear from thought leaders in industry and academia." – John M. Burke, PhD, Co-Founder, President, and CEO of Applied BioMath

Each symposium is typically comprised of two presentations from pharma and biotech researchers, along with networking opportunities. The Fall QSP-SB Industry & Academia symposium will feature Anne Heatherington, PhD, Vice President, Head of Quantitative Clinical Sciences at a leading pharmaceutical company, and Kevin Dykstra, PhD, President/CEO of qPharmetra.

About Applied BioMath

Applied BioMath (, helps biotech and pharmaceutical companies reduce late stage attrition and accelerate best-in-class (BIC) drugs using quantitative methodologies.  Leveraging biology, high performance computing (HPC), proprietary technology and experience in pharma, Applied BioMath delivers biological insights proven to shorten project timelines, lower costs, and develop BIC drugs.  Services include knowledge gap analysis, experiment prioritization and design, BIC drug property and tox predictions, indication and patient selection, and optimal clinical trial design and analysis.

Applied BioMath and the Applied BioMath logo are trademarks of Applied BioMath, LLC.

Press contact:
Kristen Zannella 

Logo -

SOURCE Applied BioMath
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. Starpharma and Makhteshim Agan in Priostar Agrochemical Collaboration
2. Regeneron Pharmaceuticals’ Industrial Operations & Product Supply Site Receives International Recognition for Operational Excellence
3. PharmAthene Reports Year-End 2012 Financial And Operational Results
4. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
5. Pharmaceutical Pricing and Health Outcomes Top Trending News This Week from HealthEconomics.Com
6. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
7. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2012 Financial Results
8. Pharmacy Automation Systems Market is Expected to Reach USD 7.8 Billion by 2018: Transparency Market Research
9. A “Fail Fast” Strategy for Lead Optimization Pharmacology and Toxicology, New Xtalks Life Sciences Webinar
10. Nutra Pharma Patent and Trademarks Published in India
11. Anthera Pharmaceuticals Reports 2012 Fourth Quarter And Fiscal Year Financial Results
Post Your Comments:
(Date:5/9/2020)... ... , ... Worldwide Business with kathy ireland® will be LIVE ... 2020 and Wednesday, May 13, 2020 at 8:00pm ET / PT – prime ... from Techolution and Bravado Pharmaceuticals . , As leaders in ...
(Date:5/1/2020)... (PRWEB) , ... April 30, 2020 , ... ... were announced today, honoring the businesses, policies, projects, and concepts that are actively ... revolutionary bioprinter for living cells, which has taken out the top prize in ...
(Date:4/22/2020)... (PRWEB) , ... April 21, 2020 , ... ... FXIII chromogenic method for determination of FXIII. , Aniara Diagnostica, a multi-national distributor ... commitment to meeting today’s highest standards for product quality and cost-efficient delivery. ...
(Date:4/7/2020)... ... April 06, 2020 , ... ... for the life sciences industry, has announced the release of at-home virtual learning ... top priority is the health and safety of our employees as we continue ...
Breaking Biology Technology:
(Date:5/11/2020)... ... May 11, 2020 , ... Octagos Health, a ... with implanted cardiac devices. The Octagos software allows healthcare professionals access to cardiac ... simplifies the management of remote transmissions and at the same time provides real-time ...
(Date:5/1/2020)... ... April 30, 2020 , ... ... diseases, announced today that it had been awarded a contract from the Biomedical ... Secretary for Preparedness and Response at the U.S. Department of Health and Human ...
(Date:4/28/2020)... Fla. (PRWEB) , ... April 27, 2020 , ... ... The first-of-its-kind category-defining service was started by three teenagers with an idea to ... in the world during the time of great need and suffering, an outlet ...
Breaking Biology News(10 mins):